Dr. Albert Keidel
{
"authors": [
"Albert Keidel"
],
"type": "legacyinthemedia",
"centerAffiliationAll": "dc",
"centers": [
"Carnegie Endowment for International Peace"
],
"collections": [],
"englishNewsletterAll": "asia",
"nonEnglishNewsletterAll": "",
"primaryCenter": "Carnegie Endowment for International Peace",
"programAffiliation": "AP",
"programs": [
"Asia"
],
"projects": [],
"regions": [
"China"
],
"topics": [
"Economy",
"Trade",
"Military"
]
}REQUIRED IMAGE
Not Everyone Agrees That China Is Trading Unfairly
Source: Financial Times
Letter to the Editor
Sir, I was pleased to be interviewed for your article "A Dollar Dilemma," but I was disappointed to see that both it and the accompanying piece, "The Clock Ticks in Washington as Friends Drift Away," left the reader with an impression that everyone agrees that China is not practicing fair trade. In fact, like myself and a number of internationally more prominent economists, the World Bank, the International Monetary Fund, and the U.S. Treasury all agree that China's exchange rate does not provide an unfair trade advantage.
The piece relies heavily on quotes from U.S. Congressional sponsors of China sanctions legislation who are understandably concerned about the appearance that China has cost their constituents jobs and profits. It neglects differing views from other reputable sources outside China.
Albert Keidel, Senior Associate, Carnegie Endowment for International Peace
About the Author
Former Senior Associate, China Program
Keidel served as acting director and deputy director for the Office of East Asian Nations at the U.S. Department of the Treasury. Before joining Treasury in 2001, he covered economic trends, system reforms, poverty, and country risk as a senior economist in the World Bank office in Beijing.
- As China's Exports Drop, Can Domestic Demand Drive Growth?Article
- China’s Fourth Quarter 2008 Statistical RecordArticle
Dr. Albert Keidel
Recent Work
More Work from Carnegie China
- Caught in the Middle: Chinese Biotech Firms’ Divergent Responses to U.S. SanctionsCommentary
Chinese biotech companies have been on the receiving end of U.S. economic coercion. Yet their responses have differed significantly because firm and state interests are not uniformly aligned. For Washington, treating all Chinese tech firms the same, irrespective of their actual interests, risks pushing them farther into Beijing’s corner.
Xue Gong
- Are Data Centers the Solution to China’s Renewables Excess Capacity?Commentary
China’s latest energy plan explicitly calls for integrating data centers into the electricity system, particularly connecting them to green energy. It appears Beijing wants to use compute as a source of domestic demand to absorb renewables excess capacity.
Damien Ma
- Trump and Xi Are Angling for Three Years of StabilityCommentary
But their "principal to principal" model will only be as effective as the political strength of each leader back home.
Damien Ma
- China Sells Stability Amid American VolatilityCommentary
U.S. unpredictability has allowed China to capitalize on its positioning as the “responsible great power”. Paradoxically, the more China wins the perception game, the more likely expectations will rise for Beijing to deliver not just words but to demonstrate with its deeds.
Chong Ja Ian
- Why Vietnam Is Swinging in China’s DirectionCommentary
Hanoi and Beijing have long treated each other as distant cousins rather than comrades in arms. That might be changing as both sides draw closer to hedge against uncertainty and America’s erratic behavior.
Nguyễn Khắc Giang